AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Dual Tasking Training to Enhance Self-Efficacy in Individuals With Parkinson's Disease

RecruitingNAAges 18 Years - anyAllAlvaro Reyes
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and cognitive impairments that substantially reduce functional independence, social participation, and quality of life. A key psychosocial factor affected by these impairments is self-efficacy, defined as an individual's belief in their ability to successfully perform tasks and achieve personal goals. In people with PD, reduced self-efficacy is closely associated with motor dysfunction, cognitive decline, fear of falling, depressive symptoms, and decreased motivation for physical and social activities. These factors interact in a bidirectional manner, creating a negative cycle in which poor confidence limits participation, further accelerating functional deterioration. From a neurophysiological perspective, the degeneration of dopaminergic neurons in PD disrupts the automatic control of movement. As a conseq

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Participants diagnosed with idiopathic Parkinson's disease confirmed by a neurologist will be recruited in this study. Inclusion criteria will be: 1. Hoehn \& Yahr stages I, II or III 2. Participants with no or mild to moderate neurocognitive impairments 3. Participants with and without symptoms of depression 4. Able to walk independently 5. Unaltered dose and type of medication up to three months before the commencement of the study 6. Participants able to understand and respond to the instructions given in the study. Exclusion criteria will be: 1. The presence of any other concomitant neurological, musculoskeletal disease 2. History of leg or brain trauma or surgery 3. Vision or hearing problems that may affect the performance of cognitive tests 4. Clinical diagnosis of major neurocognitive disorder
๐Ÿ’Š

What it tests

  • dual tasking training
๐Ÿ“

Where

1 site
Facultad de Ciencias de la Rehabilitacion
Santiago, Chile
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy